Latest News
Solvonis expands SVN-015 into depression following positive preclinical data
28 January 2026 - London-based biopharmaceutical company Solvonis Therapeutics plc (LSE: SVNS) on Wednesday announced the expansion of its investigational compound SVN-015 into the treatment of depression, supported by preclinical data showing antide...
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
28 January 2026 - Biotechnology company Biogen Inc (Nasdaq:BIIB) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for litifilimab (BIIB059) to treat cutaneous lupus erythematosus (CLE)...
Glaukos receives FDA approval for repeat administration of iDose TR
28 January 2026 - Ophthalmic pharmaceuticals and medical technology company Glaukos Corporation (NYSE:GKOS) announced on Wednesday that the US Food and Drug Administration (FDA) has approved a new drug application (NDA) labeling supplement allowing r...
Bio-Techne launches ultra-sensitive neurodegenerative disease assays on Ella platform
28 January 2026 - US life sciences tools group Bio-Techne Corporation (NASDAQ: TECH) announced on Wednesday the launch of its Simple Plex Ultra-Sensitive Assays for the Ella automated benchtop platform, expanding its immunoassay portfolio.The assays ...
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
28 January 2026 - Medical technology company Inspiration Healthcare Group plc (AIM: IHC) announced on Wednesday that its US subsidiary, Airon Corporation, has entered into a new three-year purchasing agreement with a large US healthcare provider, mar...